Share this post on:

Product Name :
Mipasetamab uzoptirine

Search keywords :
Mipasetamab uzoptirine

drugId :
null

Target Vo:
AXL receptor tyrosine kinase

Target Vo Short Name :
AXL

Moa_Name:
DNA cross linking agents

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Adc Therapeutics Sa

Active Company_Name :
Adc Therapeutics Sa

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Calnexin Rabbit pAb Autophagy
Galcanezumab References
NFAT2 Antibody: NFAT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 101 kDa, targeting to NFAT2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related